Elanco Animal Health
ELAN | NYSE
$26.41
-$0.37 (-1.38%)
At close: Nov 16, 2026, 4:00 PM ET
$27.00
+$0.59 (+2.23%)
After-hours:
Nov 16, 2026, 6:02 PM ET
Elanco Animal Health Company Profile
Company profile explainedCompany Profile
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Key Executives
| Name | Position |
|---|---|
| Jeffrey N. Simmons | President, Chief Executive Officer & Director |
| Robert VanHimbergen | Executive Vice President & Chief Financial Officer |
| David S. Kinard | Executive Vice President of Human Resources, Corporate Communications & Administration |
| Ellen de Brabander | Executive Vice President of Research, Development & Regulatory Affairs |
| James Meer | Senior Vice President & Chief Accounting Officer |
| Larbi Van Lier | Senior Vice President of Asia |
| Ramiro Martin Cabral | Executive Vice President & President of Elanco International |
| Shabbir Simjee | Chief Medical Officer |
| Shiv O'Neill | Executive Vice President, General Counsel & Corporate Secretary |
| Tiffany Ann Kanaga | Vice President of Investor Relations & ESG |
| Timothy J. Bettington | Executive Vice President of Center of Strategic Growth |
Elanco Animal Health
| Country | United States |
| IPO Date | Sep 20, 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9,650 |
| CEO | Jeffrey N. Simmons |
Contact Details
450 Elanco Circle Indianapolis,
Indiana 46221 United States
Stock Details
| Ticker Symbol | ELAN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001739104 |
| CUSIP Number | 28414H103 |
| ISIN Number | US28414H1032 |
| SIC Code | 2834 |
Recent News
- 7 days ago / seekingalpha.comElanco Animal Health Incorporated (ELAN) Presents at 2026 UBS Global Healthcare Conference Transcript
- 8 days ago / fool.comElanco Animal Health: 3 Key Takeaways for Long-Term Investors
- 10 days ago / marketbeat.comElanco Animal Health Q3 Earnings Call Highlights
- 10 days ago / seekingalpha.comElanco Animal Health Incorporated (ELAN) Q3 2026 Earnings Call Transcript
- 11 days ago / benzinga.comElanco Animal Health Sees Strong Momentum Heading Into 2027
- 11 days ago / zacks.comElanco Animal Health (ELAN) Reports Q3 Earnings: What Key Metrics Have to Say
- 11 days ago / zacks.comElanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates
- 11 days ago / prnewswire.comElanco Animal Health Reports Third Quarter 2026 Results
- 11 days ago / prnewswire.comOctober Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority
- 18 days ago / zacks.comElanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Add to Watchlist
Select watchlists to add or remove ELAN